14 Followers on Owler
OverviewCompetitorsFundingNews & Insights

BioVersys Competitors or Alternatives

BioVersys's top competitors include Debiopharm, GlycoVaxyn and Prokaryotics .

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

BioVersys's company profile

Marc Gitzinger

Founder & CEO

89/100
0
$133.5M
$ < 1M
  • $133.5M
    $ < 1M
  • 0
    $133.5M
  • $ < 1M
  • 89/100
  • 0
  • $133.5M
  • $ < 1M
View ProfileView
1
BioVersys's Competitor - Debiopharm logo

Bertrand Ducrey

CEO

69/100
250 - 500
- -
$25M - 100M
  • - -
    $25M - 100M
  • 250 - 500
    - -
  • $25M - 100M
  • 69/100
  • 250 - 500
  • - -
  • $25M - 100M
View ProfileView
2
BioVersys's Competitor - GlycoVaxyn logo

Philippe Dro

CEO

68/100
25 - 100
$22M
  • $22M
  • 25 - 100
    $22M
  • 68/100
  • 25 - 100
  • $22M
View ProfileView
3
BioVersys's Competitor - Prokaryotics logo

Keith Bostian

Interim Co-CEO

88/100
25 - 100
$7.1M
$5M - 25M
  • $7.1M
    $5M - 25M
  • 25 - 100
    $7.1M
  • $5M - 25M
  • 88/100
  • 25 - 100
  • $7.1M
  • $5M - 25M
View ProfileView
4
BioVersys's Competitor - Spero Therapeutics logo

Sath Shukla

President & CEO

82/100
150
$463.8M
$48M
  • $463.8M
    $48M
  • 150
    $463.8M
  • $48M
  • 82/100
  • 150
  • $463.8M
  • $48M
View ProfileView
5
BioVersys's Competitor - Nabriva logo

Ted Schroeder

CEO

89/100
102
$212M
$29.6M
  • $212M
    $29.6M
  • 102
    $212M
  • $29.6M
  • 89/100
  • 102
  • $212M
  • $29.6M
View ProfileView
BioVersys' top 14 competitors are Debiopharm, GlycoVaxyn, Prokaryotics , Tetraphase, Spero Therapeutics, Nabriva, Entasis, Armata, PharmaBiome, Allecra Therapeutics, Combioxin, Cidara, ContraFect and SCYNEXIS. Together they have raised over 2.2B between their estimated 1.1K employees.

BioVersys VS Debiopharm

Debiopharm is perceived as one of BioVersys's biggest rivals. Debiopharm's headquarters is in Lausanne, Vaud, and was founded in 1979. Debiopharm operates in the Pharmaceuticals industry. Debiopharm generates ∞% of BioVersys's revenue.

BioVersys VS GlycoVaxyn

GlycoVaxyn has been one of BioVersys's top competitors. GlycoVaxyn is a Private company that was founded in 06/2004 in Schlieren, Zurich. GlycoVaxyn operates in the Biotechnology industry. Compared to BioVersys, GlycoVaxyn has 40 more employees.

BioVersys VS Prokaryotics

Prokaryotics is BioVersys's #3 rival. Prokaryotics was founded in Union, New Jersey} in 2017. Prokaryotics is in the Pharmaceuticals industry. Compared to BioVersys, Prokaryotics generates $10M more revenue.

Looking for similar companies to BioVersys?

Similar Companies

Pharmaceuticals companies in Basel-City

See 24 companies 
Biotechnology companies in Basel-City

See 33 companies 
Pharmaceuticals companies in Basel

See 33 companies 
Biotechnology companies in Basel

See 53 companies 
Pharmaceuticals & Biotechnology companies in Basel-City

See 55 companies 
Pharmaceuticals & Biotechnology companies in Basel

See 88 companies 
Pharmaceuticals companies in Switzerland

See 394 companies 
Biotechnology companies in Switzerland

See 406 companies 
Pharmaceuticals & Biotechnology companies in Switzerland

See 792 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Frequently Asked Questions about BioVersys

  1. Who are BioVersys's top competitors?

    BioVersys's top 3 competitors are Debiopharm, GlycoVaxyn, Prokaryotics .

  2. Who is similar to BioVersys?

    Debiopharm is the most similar to BioVersys. GlycoVaxyn and Prokaryotics are also similar to BioVersys.

  1. Are BioVersys and Debiopharm competitors?

    Yes, Debiopharm is one of BioVersys’s top competitors.